Now in its 7th year, this is the undisputed (and only!) meeting dedicated to harnessing emerging biological understanding, employing novel preclinical models to cement translational confide
With the recent FDA approval of SYFOVRE and more decisions and approvals expected in 2023, the Complement-Based Drug Development Summit is returning for
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
